Ketamine Nasal Spray Shows Promise Against Tough-to-Treat Depression
THURSDAY, Oct. 5, 2023 (HealthDay News) — A nasal spray containing a ketamine derivative appears to beat one of the standard drugs used for people with difficult-to-treat depression, a new clinical trial has found. The trial, of nearly 700 people with treatment-resistant depression, found that esketamine nasal spray was moreContinue Reading